vs
Side-by-side financial comparison of COLLEGIUM PHARMACEUTICAL, INC (COLL) and NICOLET BANKSHARES INC (NIC). Click either name above to swap in a different company.
COLLEGIUM PHARMACEUTICAL, INC is the larger business by last-quarter revenue ($205.4M vs $104.0M, roughly 2.0× NICOLET BANKSHARES INC). NICOLET BANKSHARES INC runs the higher net margin — 38.8% vs 8.3%, a 30.5% gap on every dollar of revenue. On growth, COLLEGIUM PHARMACEUTICAL, INC posted the faster year-over-year revenue change (12.9% vs 12.5%). NICOLET BANKSHARES INC produced more free cash flow last quarter ($149.4M vs $122.4M). Over the past eight quarters, COLLEGIUM PHARMACEUTICAL, INC's revenue compounded faster (19.1% CAGR vs 12.5%).
Collegium Pharmaceutical, Inc. is a specialty pharmaceutical firm focused on developing and commercializing innovative, abuse-deterrent pain management therapies. Operating primarily in the U.S. market, it offers extended-release analgesics for chronic pain patients, serving providers across primary and specialty care segments.
Nicolet Bankshares, Inc. is a U.S. regional bank holding company based in Green Bay, Wisconsin. They are the parent company of Nicolet National Bank, the second largest Wisconsin-based bank.
COLL vs NIC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $205.4M | $104.0M |
| Net Profit | $17.0M | $40.3M |
| Gross Margin | 62.5% | — |
| Operating Margin | 29.6% | 48.3% |
| Net Margin | 8.3% | 38.8% |
| Revenue YoY | 12.9% | 12.5% |
| Net Profit YoY | 35.3% | 16.9% |
| EPS (diluted) | $0.48 | $2.63 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $205.4M | $104.0M | ||
| Q3 25 | $209.4M | $102.9M | ||
| Q2 25 | $188.0M | $95.7M | ||
| Q1 25 | $177.8M | $89.4M | ||
| Q4 24 | $181.9M | $92.4M | ||
| Q3 24 | $159.3M | $90.7M | ||
| Q2 24 | $145.3M | $85.0M | ||
| Q1 24 | $144.9M | $82.2M |
| Q4 25 | $17.0M | $40.3M | ||
| Q3 25 | $31.5M | $41.7M | ||
| Q2 25 | $12.0M | $36.0M | ||
| Q1 25 | $2.4M | $32.6M | ||
| Q4 24 | $12.5M | $34.5M | ||
| Q3 24 | $9.3M | $32.5M | ||
| Q2 24 | $19.6M | $29.3M | ||
| Q1 24 | $27.7M | $27.8M |
| Q4 25 | 62.5% | — | ||
| Q3 25 | 61.7% | — | ||
| Q2 25 | 57.7% | — | ||
| Q1 25 | 54.8% | — | ||
| Q4 24 | 54.0% | — | ||
| Q3 24 | 60.8% | — | ||
| Q2 24 | 62.5% | — | ||
| Q1 24 | 63.1% | — |
| Q4 25 | 29.6% | 48.3% | ||
| Q3 25 | 29.7% | 50.4% | ||
| Q2 25 | 18.7% | 46.8% | ||
| Q1 25 | 12.2% | 44.9% | ||
| Q4 24 | 20.9% | 46.8% | ||
| Q3 24 | 21.9% | 45.0% | ||
| Q2 24 | 32.7% | 43.3% | ||
| Q1 24 | 34.1% | 41.8% |
| Q4 25 | 8.3% | 38.8% | ||
| Q3 25 | 15.0% | 40.6% | ||
| Q2 25 | 6.4% | 37.6% | ||
| Q1 25 | 1.4% | 36.4% | ||
| Q4 24 | 6.9% | 37.3% | ||
| Q3 24 | 5.9% | 35.8% | ||
| Q2 24 | 13.5% | 34.5% | ||
| Q1 24 | 19.1% | 33.8% |
| Q4 25 | $0.48 | $2.63 | ||
| Q3 25 | $0.84 | $2.73 | ||
| Q2 25 | $0.34 | $2.34 | ||
| Q1 25 | $0.07 | $2.08 | ||
| Q4 24 | $0.36 | $2.21 | ||
| Q3 24 | $0.27 | $2.10 | ||
| Q2 24 | $0.52 | $1.92 | ||
| Q1 24 | $0.71 | $1.82 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $386.7M | — |
| Total DebtLower is stronger | — | $134.9M |
| Stockholders' EquityBook value | $301.7M | $1.3B |
| Total Assets | $1.7B | $9.2B |
| Debt / EquityLower = less leverage | — | 0.11× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $386.7M | — | ||
| Q3 25 | $285.9M | — | ||
| Q2 25 | $222.2M | — | ||
| Q1 25 | $197.8M | — | ||
| Q4 24 | $162.8M | — | ||
| Q3 24 | $120.0M | — | ||
| Q2 24 | $271.6M | — | ||
| Q1 24 | $318.0M | — |
| Q4 25 | — | $134.9M | ||
| Q3 25 | — | $134.6M | ||
| Q2 25 | — | $134.3M | ||
| Q1 25 | — | $156.6M | ||
| Q4 24 | — | $161.4M | ||
| Q3 24 | — | $161.2M | ||
| Q2 24 | — | $162.4M | ||
| Q1 24 | — | $162.3M |
| Q4 25 | $301.7M | $1.3B | ||
| Q3 25 | $274.8M | $1.2B | ||
| Q2 25 | $232.2M | $1.2B | ||
| Q1 25 | $234.4M | $1.2B | ||
| Q4 24 | $228.8M | $1.2B | ||
| Q3 24 | $234.3M | $1.1B | ||
| Q2 24 | $216.6M | $1.1B | ||
| Q1 24 | $222.2M | $1.1B |
| Q4 25 | $1.7B | $9.2B | ||
| Q3 25 | $1.6B | $9.0B | ||
| Q2 25 | $1.6B | $8.9B | ||
| Q1 25 | $1.6B | $9.0B | ||
| Q4 24 | $1.7B | $8.8B | ||
| Q3 24 | $1.6B | $8.6B | ||
| Q2 24 | $1.1B | $8.6B | ||
| Q1 24 | $1.1B | $8.4B |
| Q4 25 | — | 0.11× | ||
| Q3 25 | — | 0.11× | ||
| Q2 25 | — | 0.11× | ||
| Q1 25 | — | 0.13× | ||
| Q4 24 | — | 0.14× | ||
| Q3 24 | — | 0.14× | ||
| Q2 24 | — | 0.15× | ||
| Q1 24 | — | 0.15× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $123.0M | $153.5M |
| Free Cash FlowOCF − Capex | $122.4M | $149.4M |
| FCF MarginFCF / Revenue | 59.6% | 143.7% |
| Capex IntensityCapex / Revenue | 0.3% | 3.9% |
| Cash ConversionOCF / Net Profit | 7.25× | 3.81× |
| TTM Free Cash FlowTrailing 4 quarters | $327.6M | $275.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $123.0M | $153.5M | ||
| Q3 25 | $78.4M | $45.9M | ||
| Q2 25 | $72.4M | $38.9M | ||
| Q1 25 | $55.4M | $41.8M | ||
| Q4 24 | $84.6M | $133.7M | ||
| Q3 24 | $-9.0M | $39.6M | ||
| Q2 24 | $67.4M | $37.3M | ||
| Q1 24 | $61.9M | $23.4M |
| Q4 25 | $122.4M | $149.4M | ||
| Q3 25 | $78.3M | $45.9M | ||
| Q2 25 | $72.4M | $38.4M | ||
| Q1 25 | $54.6M | $41.3M | ||
| Q4 24 | $84.1M | $116.8M | ||
| Q3 24 | $-9.2M | $34.7M | ||
| Q2 24 | $67.1M | $34.4M | ||
| Q1 24 | $61.4M | $20.1M |
| Q4 25 | 59.6% | 143.7% | ||
| Q3 25 | 37.4% | 44.6% | ||
| Q2 25 | 38.5% | 40.1% | ||
| Q1 25 | 30.7% | 46.2% | ||
| Q4 24 | 46.2% | 126.4% | ||
| Q3 24 | -5.8% | 38.3% | ||
| Q2 24 | 46.2% | 40.5% | ||
| Q1 24 | 42.3% | 24.4% |
| Q4 25 | 0.3% | 3.9% | ||
| Q3 25 | 0.1% | 0.0% | ||
| Q2 25 | 0.0% | 0.6% | ||
| Q1 25 | 0.4% | 0.5% | ||
| Q4 24 | 0.3% | 18.3% | ||
| Q3 24 | 0.2% | 5.4% | ||
| Q2 24 | 0.2% | 3.5% | ||
| Q1 24 | 0.4% | 4.0% |
| Q4 25 | 7.25× | 3.81× | ||
| Q3 25 | 2.49× | 1.10× | ||
| Q2 25 | 6.05× | 1.08× | ||
| Q1 25 | 22.92× | 1.28× | ||
| Q4 24 | 6.75× | 3.88× | ||
| Q3 24 | -0.96× | 1.22× | ||
| Q2 24 | 3.44× | 1.28× | ||
| Q1 24 | 2.23× | 0.84× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
